ClinicalTrials.Veeva

Menu

Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis

NYU Langone Health logo

NYU Langone Health

Status

Terminated

Conditions

Multiple Sclerosis

Treatments

Device: Magnetic Resonance Imaging

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01226654
9812
2R01NS029029-16A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The primary purpose of this study is to detect changes in the brain that may be associated with multiple sclerosis. Results will be compared to age matched controls. Investigators will assess lesions by measuring T2 and T1 enhanced lesion volumes and magnetization transfer ratio histogram parameters (MTRHP) in patients with relapsing-remitting and secondary-progressive disease. This data will be correlated to total brain parenchymal volume as well as identifying the effect of MS lesions on the gray and white matter, volumetric disability, including Kurtzke Expanded Disability Status Scale (EDSS) and a specific battery of neuropsychological tests. Quantitative analysis of whole brain N-acetylaspartate (WBNAA), a reproducible measure of viable neuron number, using 1H MRS and compare the results to age-matched controls over duration of 5 years.

Enrollment

69 patients

Sex

All

Ages

7 to 110 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients with known MS diagnosis
  2. Age 7-110 years
  3. Males or females

Exclusion criteria

  1. Medically unstable
  2. Artificial implants in the body
  3. Pregnant

Normal Controls

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

69 participants in 2 patient groups

MS Patients
Other group
Description:
All subjects enrolled in this study will undergo MRI studies. A computerized neuropsychological battery of tests will be administered.
Treatment:
Device: Magnetic Resonance Imaging
Healthy Patients
Other group
Description:
Patients enrolled in this study will undergo MRI studies. A computerized neuropsychological battery of tests will be administered.
Treatment:
Device: Magnetic Resonance Imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems